1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. ARS PHARMACEUTICALS INC
ARS Pharmaceuticals Inc XNAS: SPRY

ARS Pharmaceuticals Inc Live Stock Price Today, Share Analysis and Chart

Momentum Trap
about

ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the development of novel, potentially first-in-class product candidate, neffy for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary co...

Read More
11.62 -1.24 (-9.64%)
38.52% Fall from 52W High
7.2M
XNAS Volume
High volume+loss today

XNAS 29 Aug, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Alert

Share
Durability score
Low Financial Strength
33.3 / 100
Valuation Score
Expensive Valuation
12.0 / 100
Momentum Score
Technically Neutral
43.4 / 100
Momentum Trap These stocks are the ones with poor quality and also financials and technical ranging from bad to medium score. This indicates that investors should be highly watchful with these stocks. View Similar Embed DVM
Analyst Price Target
31
1Yr Price target upside is 167%
5 analysts

6

S

14

W

3

O

2

T

SWOT Analysis

ARS Pharmaceuticals Inc Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..